The Food and Drug Administration (FDA) has approved the combination of nivolumab (Opdivo ®) plus ipilimumab (Yervoy ® ), both from Bristol Myers Squibb Company, as an option for first-line therapy for ...

Patients with MSI-H mCRC had a higher probability of survival with first-line ICI therapy than with chemotherapy, but second-line or later ICIs did not confer the same benefit.

Investigators studied cancer incidence, survival outcomes, and graft function among a multicenter cohort of kidney transplant recipients.

Researchers evaluated opioid prescribing trends by provider type for emergency department visits at noninstitutional and short-stay hospitals from 2019 to 2021.

HealthDay News — Exercise and rehabilitation services for patients with breast cancer through a clinical workflow algorithm called CORE (Comprehensive Oncology Rehabilitation and Exercise) is feasible ...

Pediatric patients with angiosarcoma were found to have a higher survival rate than their adult counterparts and may benefit from more aggressive treatments.

Overall survival after HCT for high-risk features in patients with SDS was superior to OS for HCT for MDS/AML, particularly ...

A pooled analysis of individual data from 5 COG studies demonstrated that race/ethnicity has no significant effect on survival for children and AYAs with cancer receiving treatment on clinical trial.

Results of a randomized, placebo-controlled study demonstrated avatrombopag achieved the primary endpoint of platelet response in heavily pretreated pediatric patients with persistent or chronic ITP.

Researchers examined patient-reported outcomes for quality of life following Mohs micrographic surgery for facial skin cancer.

Relative survival increased from 64% to 66%, overall survival from 54% to 55%, and lymphoma-specific survival from 64% to 66%.

Using data from the Global Burden of Disease 2021 database, researchers identified specific etiologies and other factors contributing to the burden of primary liver cancer in patients across the ...